Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
If youre still early in your treatment or havent increased your dose yet, be patientslow or nonexistent weight loss is common at first
As las cosas, SURMOUNT-1 es un ensayo clnico fase 3 multicntrico, aleatorizado, doble ciego, paralelo y controlado con placebo que compar la eficacia y seguridad de tirzepatida 5 mg, 10 mg y 15 mg frente a placebo, ambos como complemento de una dieta baja en caloras y aumento de la actividad fsica en adultos con obesidad o sobrepeso con al menos una de las siguientes complicaciones: hipertensin, dislipidemia, apnea obstructiva del sueo o enfermedad cardiovascular 1,4
As its full safety profile remains under investigation, the following reflects current available data and known class effects: Gastrointestinal symptoms are the most common: nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation
In addition, 3 mL of bacteriostatic water is needed for each vial to achieve the intended reconstitution volume
Hydration, nutrition, sleep, and stress management all influence both results and side effects
